3 hours Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Richard A. Heyman Sells 1,270 SharesMarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Richard A. Heyman sold 1,270 shares of the stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $27.67, for a total transaction of $35,140.90…
X